Sunday, July 13, 2025

Creating liberating content

Introducing deBridge Finance: Bridging...

In the dynamic landscape of decentralized finance (DeFi), innovation is a constant,...

Hyperliquid Airdrop: Everything You...

The Hyperliquid blockchain is redefining the crypto space with its lightning-fast Layer-1 technology,...

Unlock the Power of...

Join ArcInvest Today: Get $250 in Bitcoin and a 30% Deposit Bonus to...

Claim Your Hyperliquid Airdrop...

How to Claim Your Hyperliquid Airdrop: A Step-by-Step Guide to HYPE Tokens The Hyperliquid...
HomePoliticsBE wants access...

BE wants access to the IGAS report on the Portuguese-Brazilian twins case

BE wants access to a report from the General Inspectorate of Health which concluded that access to neuropediatric consultations for Portuguese-Brazilian twins treated with a drug costing millions of euros was illegal, it was announced this Friday.

In the request, signed by party coordinator Mariana Mortagua and parliamentary leader Fabian Figueiredo, the blockers refer to an IGAS statement published on Thursday with the findings and recommendations of the report, which stated “that the reference process, registration on the list and access to consultation and treatment did not comply with legal procedures “

“A number of questions therefore arise, including why this happened, on whose instructions and with what possible consequences for other users potentially awaiting consultation and treatment,” BE MPs said in the document.

BE stresses that “it is vital that the audit report is reviewed and the facts found therein made available” when requesting access to IGAS.

Chegi President Andre Ventura announced on Thursday that he would ask for the creation of a parliamentary commission to investigate the matter.

According to a report published on Thursday, the General Inspectorate of Medical Activities (IGAS) concluded that access to neuropediatric consultation for Portuguese-Brazilian twins treated at the Santa Maria Hospital with a drug worth a million euros was illegal, recommending Infarmed – National Directorate for medicines and health products comply with the scheme for submitting, assessing and approving applications for AUE in accordance with the AUE regulation provided for in the Medicines Regulations.

In a statement, Infarmed assured that they “complied in the case under consideration and will continue to comply with the current legislation in matters of AUE.”

The case of twins living in Brazil, who received Portuguese citizenship and received the drug Zolgensma in 2020 at the Santa Maria Hospital, worth a total of about four million euros, was announced by TVI in November and is still being discussed. General Prosecutor’s Office.

Earlier this year, the parliamentary transparency committee authorized former Health Minister Marta Temido and former Secretary of State António Lacerda Sales to testify to IGAS in the context of this case.

The case gave rise to some hearings in Parliament, such as those of former Justice Minister Catarina Sarmento e Castro or Infarmed President Rui Santos Ivo, but the PS rejected the hearings of the two former rulers, who said they were ready to give clarifications to the Ministry of Industry and Trade and IGAS.

Santa Maria Hospital’s internal audit had already concluded that the state Department of Health’s first appointment at the hospital was the only exception to compliance in this case.

Author: Lusa
Source: CM Jornal

Get notified whenever we post something new!

Continue reading